See more : B. Riley Financial, Inc. (RILYH) Income Statement Analysis – Financial Results
Complete financial analysis of GUJARAT INJECT (KERALA) LTD. (GUJINJEC.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of GUJARAT INJECT (KERALA) LTD., a leading company in the Medical – Distribution industry within the Healthcare sector.
You may be interested
- LegalZoom.com, Inc. (LZ) Income Statement Analysis – Financial Results
- Haein Corporation (003010.KS) Income Statement Analysis – Financial Results
- Jiangsu Zhongshe Group Co., Ltd. (002883.SZ) Income Statement Analysis – Financial Results
- Bright Health Group, Inc. (BHG) Income Statement Analysis – Financial Results
- Belluna Co., Ltd. (9997.T) Income Statement Analysis – Financial Results
GUJARAT INJECT (KERALA) LTD. (GUJINJEC.BO)
About GUJARAT INJECT (KERALA) LTD.
Gujarat Inject (Kerala) Ltd. engages in the trading of textile fabrics. The company was founded on January 7, 1991 and is headquartered in Gujarat, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 57.88M | 1.74M | 226.00K | 115.50K | 0.00 |
| Cost of Revenue | 54.03M | 1.54M | 155.24K | 89.19K | 0.00 |
| Gross Profit | 3.85M | 199.26K | 70.76K | 26.31K | 0.00 |
| Gross Profit Ratio | 6.66% | 11.47% | 31.31% | 22.78% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 3.02M | 3.69M | 386.35K | 1.14M | 19.30K |
| Selling & Marketing | 87.04K | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 3.11M | 3.69M | 386.35K | 1.14M | 19.30K |
| Other Expenses | 741.65K | 4.32M | 482.24K | 82.00K | 53.00K |
| Operating Expenses | 3.85M | 3.97M | 529.35K | 1.16M | 50.80K |
| Cost & Expenses | 57.88M | 5.51M | 684.58K | 1.25M | 50.80K |
| Interest Income | 2.36K | 630.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 4.00K | 501.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 603.98K | 228.49K | 236.56K | 206.30K | 171.86K |
| EBITDA | 1.05M | 554.90K | 29.50K | -1.05M | 2.20K |
| EBITDA Ratio | 1.82% | 31.93% | 13.05% | -911.24% | 0.00% |
| Operating Income | 448.65K | 554.90K | 29.50K | -1.05M | 2.20K |
| Operating Income Ratio | 0.78% | 31.93% | 13.05% | -911.24% | 0.00% |
| Total Other Income/Expenses | 603.98K | 4.31M | 488.08K | 82.00K | 0.00 |
| Income Before Tax | 1.05M | 554.90K | 29.50K | -1.05M | 2.20K |
| Income Before Tax Ratio | 1.82% | 31.93% | 13.05% | -911.24% | 0.00% |
| Income Tax Expense | 225.00K | 144.44K | 7.40K | -206.30K | -171.86K |
| Net Income | 827.63K | 410.00K | 22.10K | -1.05M | 2.20K |
| Net Income Ratio | 1.43% | 23.59% | 9.78% | -911.24% | 0.00% |
| EPS | 0.18 | 0.05 | 0.00 | -0.21 | 0.00 |
| EPS Diluted | 0.18 | 0.05 | 0.00 | -0.21 | 0.00 |
| Weighted Avg Shares Out | 4.60M | 4.90M | 4.90M | 4.90M | 4.90M |
| Weighted Avg Shares Out (Dil) | 4.60M | 4.90M | 4.90M | 4.90M | 4.90M |
No news found for: GUJINJEC.BO
Source: https://incomestatements.info
Category: Stock Reports